Is high-level immunogenicity achieved vaccine with adjuvanted pandemic H1N1 ( 2009 ) and improved with booster dosing in a randomized trial of HIV-infected adults?
High-level immunogenicity was achieved with a single dose of this adjuvanted vaccine. Immunogenicity was further improved with booster dosing. Use of this adjuvanted vaccine and booster represent an important approach to increasing immunogenicity in this vaccine hypo-responsive population.
The tissue type in the stapler distal doughnut did not greatly influence functional outcome. Failure to identify a relationship may attest to the variable height and composition of the anal transitional zone.